'Watershed moment’ as London medtech closes £1.75m funding round

Jun 4, 2018 · bdaily.co.uk


The medtech company behind a new blood filtration device has secured seven-figure funding.

London-based MediSieve Ltd secured the £1.75m boost from a mix of new and existing investors.

Private capital network 24Haymarket led the round by contributing £632k, with director Marek Gumienny joining the MediSieve board as non-executive director.

MediSieve said the investment will "contribute greatly" to further research and development while providing a strong source of future capital.

The company currently operates from office and lab space at Imperial College London’s Translation & Innovation Hub (I-HUB).

MediSieve is best known for its magnetic blood filtration technology, which targets blood-borne diseases by magnetically filtering specific disease-causing components in the bloodstream.

Read Complete Article

RT @unboundglobal: It's back! Save the date for #UnboundLDN: 17 & 18 July. Back at the iconic Old Truman Brewery for the sixth year with 5,…

RT @HackneyWNS: Please contact #Tell_StreetLink if you are concerned about a rough sleeper. https://t.co/pI8ezrwl1A

#TechX365: A new service designed to streamline UK company registrations has already been used more than 200,000 ti… https://t.co/0nlJj0vJcv

Workforce data has promise and a good bit of peril, says Accenture https://t.co/19G5zOVxlo by @ldignan

😊 😊 😊 Nice. Community Manager at @trussle https://t.co/Z5127xg0Sl #marketing #community